Natera (NTRA) Revenue & Revenue Breakdown
Natera Revenue Highlights
Latest Revenue (Y)
$1.08B
Latest Revenue (Q)
$413.35M
Main Segment (Y)
Product
Main Geography (Y)
United States
Natera Revenue by Period
Natera Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $1.08B | 31.99% |
| 2022-12-31 | $820.22M | 31.13% |
| 2021-12-31 | $625.49M | 59.97% |
| 2020-12-31 | $391.00M | 29.33% |
| 2019-12-31 | $302.33M | 17.34% |
| 2018-12-31 | $257.65M | 22.15% |
| 2017-12-31 | $210.94M | -2.83% |
| 2016-12-31 | $217.07M | 14.04% |
| 2015-12-31 | $190.35M | 19.50% |
| 2014-12-31 | $159.29M | 188.72% |
| 2013-12-31 | $55.17M | - |
Natera generated $1.08B in revenue during NA 2023, up 31.99% compared to the previous quarter, and up 420.16% compared to the same period a year ago.
Natera Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $413.35M | 12.40% |
| 2024-03-31 | $367.74M | 18.20% |
| 2023-12-31 | $311.11M | 15.95% |
| 2023-09-30 | $268.31M | 2.64% |
| 2023-06-30 | $261.40M | 8.13% |
| 2023-03-31 | $241.76M | 11.28% |
| 2022-12-31 | $217.25M | 3.14% |
| 2022-09-30 | $210.64M | 6.27% |
| 2022-06-30 | $198.20M | 2.09% |
| 2022-03-31 | $194.13M | 12.20% |
| 2021-12-31 | $173.03M | 9.43% |
| 2021-09-30 | $158.12M | 11.33% |
| 2021-06-30 | $142.03M | -6.76% |
| 2021-03-31 | $152.32M | 35.54% |
| 2020-12-31 | $112.38M | 14.50% |
| 2020-09-30 | $98.14M | 13.50% |
| 2020-06-30 | $86.47M | -8.02% |
| 2020-03-31 | $94.01M | 12.94% |
| 2019-12-31 | $83.24M | 6.84% |
| 2019-09-30 | $77.91M | 4.78% |
| 2019-06-30 | $74.36M | 11.27% |
| 2019-03-31 | $66.82M | -0.21% |
| 2018-12-31 | $66.97M | 2.58% |
| 2018-09-30 | $65.28M | 3.51% |
| 2018-06-30 | $63.07M | 1.17% |
| 2018-03-31 | $62.34M | 15.95% |
| 2017-12-31 | $53.77M | -5.10% |
| 2017-09-30 | $56.66M | 5.67% |
| 2017-06-30 | $53.62M | 14.32% |
| 2017-03-31 | $46.90M | -4.86% |
| 2016-12-31 | $49.30M | -8.52% |
| 2016-09-30 | $53.89M | 3.66% |
| 2016-06-30 | $51.98M | -16.02% |
| 2016-03-31 | $61.90M | 16.99% |
| 2015-12-31 | $52.91M | 17.79% |
| 2015-09-30 | $44.92M | -0.37% |
| 2015-06-30 | $45.09M | -4.95% |
| 2015-03-31 | $47.44M | -4.91% |
| 2014-12-31 | $49.88M | 7.80% |
| 2014-09-30 | $46.27M | 29.13% |
| 2014-06-30 | $35.84M | 31.29% |
| 2014-03-31 | $27.30M | - |
Natera generated $413.35M in revenue during Q2 2024, up 12.40% compared to the previous quarter, and up 170.98% compared to the same period a year ago.
Natera Revenue Breakdown
Natera Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Product | $1.07B | $797.31M | $567.15M | $367.21M | $269.88M |
| Genetic testing services | $18.30M | - | - | - | - |
| Oncology products | $19.30M | - | - | - | - |
| Licensing and other | $14.05M | $22.91M | $58.34M | - | - |
| Licensing And Other | - | - | - | $23.79M | $32.45M |
| Other Licensing And Other | - | - | - | - | $10.98M |
| Upfront License And Constellation And Paternity Services | - | - | - | - | $5.09M |
| License And Development Services | - | - | - | - | $16.38M |
Natera's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (95.39%), Oncology products (1.72%), Genetic testing services (1.63%), and Licensing and other (1.25%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product | $364.67M | $572.47M | $258.26M | $237.80M | $212.89M | $199.83M | $194.58M | $190.00M | $160.88M | $150.65M | $137.23M | $118.38M | $106.47M | $93.29M | $80.41M | $87.05M | $74.48M | $66.94M | $65.10M | $63.36M |
| Licensing and other | $3.07M | $6.94M | $3.15M | $3.96M | $4.36M | $10.81M | $3.62M | $4.13M | $12.14M | - | - | - | - | - | - | - | - | - | - | - |
| Oncology products | - | - | $19.30M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Royalty | - | - | $20.00M | $600.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Licensing And Other | - | - | - | - | - | - | - | - | - | $7.46M | $4.79M | $33.93M | $5.91M | $4.86M | $6.06M | $6.97M | $8.76M | $10.97M | $9.26M | $3.46M |
| Other Licensing And Other Revenue | - | - | - | - | - | - | - | - | - | - | - | $10.00M | - | - | - | - | - | - | - | - |
| Upfront License And Constellation And Paternity Services | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.37M | - | - | - | - |
| Other Licensing And Other | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $797.00K | $3.72M | $2.88M | $2.40M | $1.98M |
| License And Development Services | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $4.80M | - | - | - | - |
| Constellation | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.25M | $1.31M | $1.33M |
| Other Genetic Tests | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $3.23M | $4.35M | $3.37M |
| Qiagen | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $527.00K | $148.00K |
| Hcs | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $26.15M | $24.29M | $22.75M |
| Panorama Nipt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $37.56M | $36.47M | $37.25M |
| Bgi Genomics Co Ltd | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $6.84M | $5.02M | - |
Natera's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Product (99.17%), and Licensing and other (0.83%).
Natera Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Asia Pacific and Other | $7.22M | $14.03M | $10.14M | - | - |
| Americas, excluding U.S. | $4.91M | $3.71M | $4.05M | - | - |
| United States | $1.05B | $785.85M | $590.87M | - | - |
| Europe, Middle East, India, and Africa | $22.81M | $16.64M | $20.43M | - | - |
| Europe Middle East India And Africa | - | - | - | $14.33M | $15.43M |
| Americas Excluding Us | - | - | - | $3.47M | $3.22M |
| Other Geographic Areas | - | - | - | $7.54M | $22.83M |
| U | - | - | - | $365.66M | $260.85M |
Natera's latest annual revenue breakdown by geography, as of Dec 23: United States (96.77%), Europe, Middle East, India, and Africa (2.11%), Asia Pacific and Other (0.67%), and Americas, excluding U.S. (0.45%).
Quarterly Revenue by Country
| Country | Mar 24 | Dec 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia Pacific and Other | $1.67M | $3.79M | $1.28M | $2.15M | $2.04M | $7.46M | $2.05M | $2.48M | $2.86M | - | - | - | - | - | - | - | - | - | - | - |
| Americas, excluding U.S. | $1.48M | $2.54M | $1.21M | $1.16M | $1.28M | $1.16M | $530.00K | $741.00K | $995.00K | - | - | - | - | - | - | - | - | - | - | - |
| Europe, Middle East, India, Africa | $5.18M | $5.62M | $5.20M | $4.96M | $3.74M | $3.69M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| United States | $359.41M | $561.09M | $253.30M | $233.25M | $209.68M | $197.07M | $191.89M | $187.22M | $163.07M | - | - | - | - | - | - | - | - | - | - | - |
| Americas Excluding Us | - | - | - | - | - | - | - | - | - | $1.25M | $992.00K | $813.00K | $885.00K | $1.08M | $721.00K | $782.00K | $827.00K | $806.00K | $767.00K | $818.00K |
| E M E A | - | - | - | - | - | - | - | - | - | $5.60M | $4.26M | $4.46M | $3.52M | $3.58M | $3.48M | $3.50M | $4.32M | $4.00M | - | - |
| Other Geographic Areas | - | - | - | - | - | - | - | - | - | $3.24M | $1.96M | $2.09M | $3.08M | $27.00K | $1.41M | $3.02M | $5.47M | $8.77M | $6.88M | $1.72M |
| U | - | - | - | - | - | - | - | - | - | $148.03M | $134.81M | $144.96M | $104.66M | $93.51M | $80.76M | $86.73M | $73.33M | $64.84M | $62.39M | $60.28M |
Natera's latest quarterly revenue breakdown by geography, as of Mar 24: United States (97.74%), Europe, Middle East, India, Africa (1.41%), Asia Pacific and Other (0.45%), and Americas, excluding U.S. (0.40%).
Natera Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ILMN | Illumina | $4.50B | $1.08B |
| EXAS | Exact Sciences | $2.50B | $699.26M |
| QGEN | Qiagen | $1.97B | $458.80M |
| NTRA | Natera | $1.08B | $413.35M |
| NEOG | Neogen | $924.22M | $228.81M |
| GTH | Genetron | $650.71M | $201.32M |
| NEO | NeoGenomics | $591.64M | $164.50M |
| GH | Guardant Health | $563.95M | $177.24M |
| CDNA | CareDx | $280.32M | $92.27M |
| TWST | Twist Bioscience | $245.11M | $81.46M |
| CSTL | Castle Biosciences | $219.79M | $87.00M |
| PSNL | Personalis | $73.48M | $19.52M |
| DRIO | DarioHealth | $20.35M | $6.25M |
| SERA | Sera Prognostics | $306.00K | - |
NTRA Revenue FAQ
What is Natera’s yearly revenue?
Natera's yearly revenue for 2023 was $1.08B, representing an increase of 31.99% compared to 2022. The company's yearly revenue for 2022 was $820.22M, representing an increase of 31.13% compared to 2021. NTRA's yearly revenue for 2021 was $625.49M, representing an increase of 59.97% compared to 2020.
What is Natera’s quarterly revenue?
Natera's quarterly revenue for Q2 2024 was $413.35M, a 12.40% increase from the previous quarter (Q1 2024), and a 58.13% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $367.74M, a 18.20% increase from the previous quarter (Q4 2023), and a 52.11% increase year-over-year (Q1 2023). NTRA's quarterly revenue for Q4 2023 was $311.1M, a 15.95% increase from the previous quarter (Q3 2023), and a 43.20% increase year-over-year (Q4 2022).
What is Natera’s revenue growth rate?
Natera's revenue growth rate for the last 3 years (2021-2023) was 73.08%, and for the last 5 years (2019-2023) was 258.08%.
What are Natera’s revenue streams?
Natera's revenue streams in c 23 are Product, Genetic testing services, Oncology products, and Licensing and other. Product generated $1.07B in revenue, accounting 95.39% of the company's total revenue, up 34.02% year-over-year. Genetic testing services generated $18.3M in revenue, accounting 1.63% of the company's total revenue Oncology products generated $19.3M in revenue, accounting 1.72% of the company's total revenue Licensing and other generated $14.05M in revenue, accounting 1.25% of the company's total revenue, down -38.69% year-over-year.
What is Natera’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Natera was Product. This segment made a revenue of $1.07B, representing 95.39% of the company's total revenue.